Chi - Submitted regulatory filing for first-in-human clinical study of KRRO-110 in patients with alpha-1 antitrypsin deficiency (AATD) - Formed Clinical Advisory Board (CAB) of leading lung and ...

Charles Schwab Investment Management Inc. lifted its holdings in Beam Therapeutics Inc ... a liver-targeting LNP formulation ...

Sunway Medical Centre, Sunway City consultant physician, respiratory medicine and interventional pulmonologist Dr Syed Ajmal Syed Ali said that low awareness is one of Malaysia's biggest challenges in ...

In 2024, startups saw a notable resurgence in large-scale funding rounds. By May, over 100 startups had secured funding ...

Fintel reports that on December 6, 2024, Jefferies initiated coverage of Mereo BioPharma Group plc - Depositary Receipt () ...

A new year means a new Fierce Biotech Fundraising Tracker to record all the venture capital being funneled into the industry for 2024. We're bumping up our reporting criteria from last year's ...

From volatility and geopolitics to economic trends and investment outlooks, stay informed on the key developments shaping today's markets.

Outlined below is what Oppenheimer Asset Management had to say about AVGO, BLDR, and EW along with some general market stats and Seeking Alpha quant ... AVGO is +52.1% year-to-date.